Sulministro de Etelcadetida (DOE), Romiplostim (DOE), Panitumumab (DOE), Darbepoetina Alfa (DOE) Y Inebilizumab (DOE)

Deadline:N/A

Tender information
Araba/Álava
Type
Contract award
Procedure
Negotiated without a call for competition
Ref. number
2026/01730
Estimated value
€9,909,185.52
Duration
5 years
Sulministro de Etelcadetida (DOE), Romiplostim (DOE), Panitumumab (DOE), Darbepoetina Alfa (DOE) Y Inebilizumab (DOE)

1 - L1_ETELCALCETIDA (DOE)

L1_ETELCALCETIDA (DOE)

2 - L2_ROMIPLOSTIM (DOE)

L2_ROMIPLOSTIM (DOE)

3 - L3_PANITUMUMAB (DOE)

L3_PANITUMUMAB (DOE)

4 - L4_DARBEPOETINA (DOE)

L4_DARBEPOETINA (DOE)

5 - L5_INEBILIZUMAB (DOE)

L5_INEBILIZUMAB (DOE)

Buyer
OSAKIDETZA - Servicio Vasco de Salud - Organización Central
buyer-email@mail.com
organization number
Contract award
tenderer iconAMGEN, S.A.tenderer status icon trophyAwarded
Contract awarded
Important dates
17 Nov - Publication date
Unlock Full Access with Mercell Bidding Business Plus
Start your free trial to explore exclusive features that help you win more tenders, faster:
AI-Powered Tender Insights
Buyer Contact Info
Key Tender Timelines

Already have an account?